Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 24/08/22 → 30/06/26 |
Funding
- Vertex Pharmaceuticals (Aust) Pty Ltd: A$83,099.00
A Phase 3, Open-label Study Evaluating the Longterm Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
- Mulrennan, Siobhain (Investigator 01)